Moreover, many epidemiological studies have shown an association between CRP and cardiovascular risk [119], and its clinical utility is currently a topic of great debate, with novel proposals for scenarios where its evaluation may be useful, including the use of fractions of CRP as a new element in the diagnostic workup of patients with acute coronary syndrome [120] and the designation of CRP as a potential therapeutic target given its exhaustive involvement in the pathophysiology of atherosclerosis [121]. This evidence concerns the gene CRP and acute coronary syndrome.